1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Treatment for Communicable Diseases Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 HIV 1.2.3 Influenza 1.2.4 TB 1.2.5 Malaria 1.2.6 Hepatitis 1.2.7 HPV 1.3 Market by Application 1.3.1 Global Treatment for Communicable Diseases Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Treatment for Communicable Diseases Market Perspective (2017-2028) 2.2 Treatment for Communicable Diseases Growth Trends by Region 2.2.1 Treatment for Communicable Diseases Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Treatment for Communicable Diseases Historic Market Size by Region (2017-2022) 2.2.3 Treatment for Communicable Diseases Forecasted Market Size by Region (2023-2028) 2.3 Treatment for Communicable Diseases Market Dynamics 2.3.1 Treatment for Communicable Diseases Industry Trends 2.3.2 Treatment for Communicable Diseases Market Drivers 2.3.3 Treatment for Communicable Diseases Market Challenges 2.3.4 Treatment for Communicable Diseases Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Treatment for Communicable Diseases Players by Revenue 3.1.1 Global Top Treatment for Communicable Diseases Players by Revenue (2017-2022) 3.1.2 Global Treatment for Communicable Diseases Revenue Market Share by Players (2017-2022) 3.2 Global Treatment for Communicable Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Treatment for Communicable Diseases Revenue 3.4 Global Treatment for Communicable Diseases Market Concentration Ratio 3.4.1 Global Treatment for Communicable Diseases Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Treatment for Communicable Diseases Revenue in 2021 3.5 Treatment for Communicable Diseases Key Players Head office and Area Served 3.6 Key Players Treatment for Communicable Diseases Product Solution and Service 3.7 Date of Enter into Treatment for Communicable Diseases Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Treatment for Communicable Diseases Breakdown Data by Type 4.1 Global Treatment for Communicable Diseases Historic Market Size by Type (2017-2022) 4.2 Global Treatment for Communicable Diseases Forecasted Market Size by Type (2023-2028) 5 Treatment for Communicable Diseases Breakdown Data by Application 5.1 Global Treatment for Communicable Diseases Historic Market Size by Application (2017-2022) 5.2 Global Treatment for Communicable Diseases Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Treatment for Communicable Diseases Market Size (2017-2028) 6.2 North America Treatment for Communicable Diseases Market Size by Country (2017-2022) 6.3 North America Treatment for Communicable Diseases Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Treatment for Communicable Diseases Market Size (2017-2028) 7.2 Europe Treatment for Communicable Diseases Market Size by Country (2017-2022) 7.3 Europe Treatment for Communicable Diseases Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Treatment for Communicable Diseases Market Size (2017-2028) 8.2 Asia-Pacific Treatment for Communicable Diseases Market Size by Country (2017-2022) 8.3 Asia-Pacific Treatment for Communicable Diseases Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Treatment for Communicable Diseases Market Size (2017-2028) 9.2 Latin America Treatment for Communicable Diseases Market Size by Country (2017-2022) 9.3 Latin America Treatment for Communicable Diseases Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Treatment for Communicable Diseases Market Size (2017-2028) 10.2 Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2017-2022) 10.3 Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Detail 11.1.2 Novartis Business Overview 11.1.3 Novartis Treatment for Communicable Diseases Introduction 11.1.4 Novartis Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.1.5 Novartis Recent Development 11.2 Gilead 11.2.1 Gilead Company Detail 11.2.2 Gilead Business Overview 11.2.3 Gilead Treatment for Communicable Diseases Introduction 11.2.4 Gilead Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.2.5 Gilead Recent Development 11.3 GSK 11.3.1 GSK Company Detail 11.3.2 GSK Business Overview 11.3.3 GSK Treatment for Communicable Diseases Introduction 11.3.4 GSK Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.3.5 GSK Recent Development 11.4 Janssen Pharmaceutical 11.4.1 Janssen Pharmaceutical Company Detail 11.4.2 Janssen Pharmaceutical Business Overview 11.4.3 Janssen Pharmaceutical Treatment for Communicable Diseases Introduction 11.4.4 Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.4.5 Janssen Pharmaceutical Recent Development 11.5 Roche 11.5.1 Roche Company Detail 11.5.2 Roche Business Overview 11.5.3 Roche Treatment for Communicable Diseases Introduction 11.5.4 Roche Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.5.5 Roche Recent Development 11.6 BioCryst Pharmaceuticals 11.6.1 BioCryst Pharmaceuticals Company Detail 11.6.2 BioCryst Pharmaceuticals Business Overview 11.6.3 BioCryst Pharmaceuticals Treatment for Communicable Diseases Introduction 11.6.4 BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.6.5 BioCryst Pharmaceuticals Recent Development 11.7 Merck 11.7.1 Merck Company Detail 11.7.2 Merck Business Overview 11.7.3 Merck Treatment for Communicable Diseases Introduction 11.7.4 Merck Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.7.5 Merck Recent Development 11.8 Boehringer Ingelheim 11.8.1 Boehringer Ingelheim Company Detail 11.8.2 Boehringer Ingelheim Business Overview 11.8.3 Boehringer Ingelheim Treatment for Communicable Diseases Introduction 11.8.4 Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2017-2022) 11.8.5 Boehringer Ingelheim Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Treatment for Communicable Diseases Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of HIV Table 3. Key Players of Influenza Table 4. Key Players of TB Table 5. Key Players of Malaria Table 6. Key Players of Hepatitis Table 7. Key Players of HPV Table 8. Global Treatment for Communicable Diseases Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Treatment for Communicable Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Treatment for Communicable Diseases Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Treatment for Communicable Diseases Market Share by Region (2017-2022) Table 12. Global Treatment for Communicable Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Treatment for Communicable Diseases Market Share by Region (2023-2028) Table 14. Treatment for Communicable Diseases Market Trends Table 15. Treatment for Communicable Diseases Market Drivers Table 16. Treatment for Communicable Diseases Market Challenges Table 17. Treatment for Communicable Diseases Market Restraints Table 18. Global Treatment for Communicable Diseases Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Treatment for Communicable Diseases Market Share by Players (2017-2022) Table 20. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment for Communicable Diseases as of 2021) Table 21. Ranking of Global Top Treatment for Communicable Diseases Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Treatment for Communicable Diseases Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Treatment for Communicable Diseases Product Solution and Service Table 25. Date of Enter into Treatment for Communicable Diseases Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Treatment for Communicable Diseases Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Treatment for Communicable Diseases Revenue Market Share by Type (2017-2022) Table 29. Global Treatment for Communicable Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Treatment for Communicable Diseases Revenue Market Share by Type (2023-2028) Table 31. Global Treatment for Communicable Diseases Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Treatment for Communicable Diseases Revenue Market Share by Application (2017-2022) Table 33. Global Treatment for Communicable Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Treatment for Communicable Diseases Revenue Market Share by Application (2023-2028) Table 35. North America Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific Treatment for Communicable Diseases Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa Treatment for Communicable Diseases Market Size by Country (2023-2028) & (US$ Million) Table 45. Novartis Company Detail Table 46. Novartis Business Overview Table 47. Novartis Treatment for Communicable Diseases Product Table 48. Novartis Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 49. Novartis Recent Development Table 50. Gilead Company Detail Table 51. Gilead Business Overview Table 52. Gilead Treatment for Communicable Diseases Product Table 53. Gilead Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 54. Gilead Recent Development Table 55. GSK Company Detail Table 56. GSK Business Overview Table 57. GSK Treatment for Communicable Diseases Product Table 58. GSK Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 59. GSK Recent Development Table 60. Janssen Pharmaceutical Company Detail Table 61. Janssen Pharmaceutical Business Overview Table 62. Janssen Pharmaceutical Treatment for Communicable Diseases Product Table 63. Janssen Pharmaceutical Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 64. Janssen Pharmaceutical Recent Development Table 65. Roche Company Detail Table 66. Roche Business Overview Table 67. Roche Treatment for Communicable Diseases Product Table 68. Roche Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 69. Roche Recent Development Table 70. BioCryst Pharmaceuticals Company Detail Table 71. BioCryst Pharmaceuticals Business Overview Table 72. BioCryst Pharmaceuticals Treatment for Communicable Diseases Product Table 73. BioCryst Pharmaceuticals Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 74. BioCryst Pharmaceuticals Recent Development Table 75. Merck Company Detail Table 76. Merck Business Overview Table 77. Merck Treatment for Communicable Diseases Product Table 78. Merck Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 79. Merck Recent Development Table 80. Boehringer Ingelheim Company Detail Table 81. Boehringer Ingelheim Business Overview Table 82. Boehringer Ingelheim Treatment for Communicable Diseases Product Table 83. Boehringer Ingelheim Revenue in Treatment for Communicable Diseases Business (2017-2022) & (US$ Million) Table 84. Boehringer Ingelheim Recent Development Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources List of Figures Figure 1. Global Treatment for Communicable Diseases Market Share by Type: 2021 VS 2028 Figure 2. HIV Features Figure 3. Influenza Features Figure 4. TB Features Figure 5. Malaria Features Figure 6. Hepatitis Features Figure 7. HPV Features Figure 8. Global Treatment for Communicable Diseases Market Share by Application in 2021 & 2028 Figure 9. Hospital Case Studies Figure 10. Clinic Case Studies Figure 11. Other Case Studies Figure 12. Treatment for Communicable Diseases Report Years Considered Figure 13. Global Treatment for Communicable Diseases Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Treatment for Communicable Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Treatment for Communicable Diseases Market Share by Region: 2021 VS 2028 Figure 16. Global Treatment for Communicable Diseases Market Share by Players in 2021 Figure 17. Global Top Treatment for Communicable Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment for Communicable Diseases as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Treatment for Communicable Diseases Revenue in 2021 Figure 19. North America Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America Treatment for Communicable Diseases Market Share by Country (2017-2028) Figure 21. United States Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Treatment for Communicable Diseases Market Share by Country (2017-2028) Figure 25. Germany Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Treatment for Communicable Diseases Market Share by Region (2017-2028) Figure 33. China Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Treatment for Communicable Diseases Market Share by Country (2017-2028) Figure 41. Mexico Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Treatment for Communicable Diseases Market Share by Country (2017-2028) Figure 45. Turkey Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia Treatment for Communicable Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Novartis Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 48. Gilead Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 49. GSK Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 50. Janssen Pharmaceutical Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 51. Roche Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 52. BioCryst Pharmaceuticals Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 53. Merck Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 54. Boehringer Ingelheim Revenue Growth Rate in Treatment for Communicable Diseases Business (2017-2022) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Novartis Gilead GSK Janssen Pharmaceutical Roche BioCryst Pharmaceuticals Merck Boehringer Ingelheim